TC
AVNS

TwinBeech Capital’s Avanos Medical AVNS Stock Holding History

TwinBeech Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,218
Closed -$512K – 591
2023
Q1 		$512K Buy
+17,218
New +$500K 0.01% 509
2021
Q4 		– Sell
-19,066
Closed -$595K – 562
2021
Q3 		$595K Buy
+19,066
New +$647K 0.04% 413
2021
Q1 		– Sell
-5,041
Closed -$231K – 451
2020
Q4 		$231K Sell
5,041
-3,213
-39% -$134K 0.04% 392
2020
Q3 		$274K Buy
+8,254
New +$264K 0.06% 358

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TwinBeech Capital's AVNS Position: Q2 2023 in Review

TwinBeech Capital sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 17,218 shares — an estimated $512K sold.

TwinBeech Capital first reported a position in AVNS in Q3 2020 and held it in 4 quarters. The position peaked at $595K in Q3 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • TwinBeech Capital reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • TwinBeech Capital sold 17,218 Avanos Medical shares in Q2 2023, an estimated $512K.
  • TwinBeech Capital first reported a position in Avanos Medical in Q3 2020 and held it in 4 quarters.
  • TwinBeech Capital's Avanos Medical position peaked at $595K in Q3 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on TwinBeech Capital's 13F filing for Q2 2023, filed 14 Aug 2023.